These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36396512)

  • 1. Use of catch-up vaccinations in the second year of life (2YL) platform to close immunity gaps: A secondary DHS analysis in Pakistan, Philippines, and South Africa.
    Manandhar P; Wannemuehler K; Danovaro-Holliday MC; Nic Lochlainn L; Shendale S; Sodha SV
    Vaccine; 2023 Jan; 41(1):61-67. PubMed ID: 36396512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization delivery in the second year of life in Ghana: the need for a multi-faceted approach.
    Nyaku M; Wardle M; Eng JV; Ametewee L; Bonsu G; Larbi Opare JK; Conklin L
    Pan Afr Med J; 2017; 27(Suppl 3):4. PubMed ID: 29296139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timeliness of Childhood Vaccinations Following Strengthening of the Second Year of Life (2YL) Immunization Platform and Introduction of Catch-Up Vaccination Policy in Ghana.
    Muhoza P; Shah MP; Amponsa-Achiano K; Gao H; Quaye P; Opare W; Okae C; Aboyinga PN; Opare JKL; Ehlman DC; Wardle MT; Wallace AS
    Vaccines (Basel); 2024 Jun; 12(7):. PubMed ID: 39066354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing immunization during second year of life by reducing missed opportunities for vaccinations in 46 countries.
    Hanson CM; Mirza I; Kumapley R; Ogbuanu I; Kezaala R; Nandy R
    Vaccine; 2018 May; 36(23):3260-3268. PubMed ID: 29731113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum to "Use of catch-up vaccinations in the second year of life (2YL) platform to close immunity gaps: A secondary DHS analysis in Pakistan, Philippines, and South Africa" [Vaccine 41(1) (2023) 61-67].
    Manandhar P; Wannemuehler K; Danovaro-Holliday MC; Nic Lochlainn L; Shendale S; Sodha SV
    Vaccine; 2023 Mar; 41(14):2423-2424. PubMed ID: 36898930
    [No Abstract]   [Full Text] [Related]  

  • 6. Avoiding missed opportunities for immunization in the Central African Republic: potential impact on vaccination coverage.
    Kahn JG; Mokdad AH; Deming MS; Roungou JB; Boby AM; Excler JL; Waldman RJ
    Bull World Health Organ; 1995; 73(1):47-55. PubMed ID: 7704925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of vaccine wastage rates, missed opportunities, and related knowledge, attitudes and practices during introduction of a second dose of measles-containing vaccine into Cambodia's national immunization program.
    Wallace AS; Krey K; Hustedt J; Burnett E; Choun N; Daniels D; Watkins ML; Soeung SC; Duncan R
    Vaccine; 2018 Jul; 36(30):4517-4524. PubMed ID: 29907485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the COVID-19 Pandemic on Measles Vaccination Coverage and Estimated Catch-up Efforts for Serbia.
    Burgess C; Lisul B; Pawaskar M; Petigara T; Murtagh J; Kanazir M; Loncarevic G; Carias C
    Pediatr Infect Dis J; 2024 Oct; 43(10):1011-1017. PubMed ID: 39105529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study.
    Causey K; Fullman N; Sorensen RJD; Galles NC; Zheng P; Aravkin A; Danovaro-Holliday MC; Martinez-Piedra R; Sodha SV; Velandia-González MP; Gacic-Dobo M; Castro E; He J; Schipp M; Deen A; Hay SI; Lim SS; Mosser JF
    Lancet; 2021 Aug; 398(10299):522-534. PubMed ID: 34273292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine Vaccination Coverage - Worldwide, 2020.
    Muhoza P; Danovaro-Holliday MC; Diallo MS; Murphy P; Sodha SV; Requejo JH; Wallace AS
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(43):1495-1500. PubMed ID: 34710074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timeliness of immunisation with the pentavalent vaccine at different levels of the health care system in the Lao People's Democratic Republic: A cross-sectional study.
    Hefele L; Syphan S; Xayavong D; Homsana A; Kleine D; Chanthavilay P; Nouanthong P; Xaydalasouk K; Phathammavong O; Billamay S; Xeuatvongsa A; Reinharz D; Black AP; Muller CP
    PLoS One; 2020; 15(12):e0242502. PubMed ID: 33290386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis.
    Castrejon MM; Leal I; de Jesus Pereira Pinto T; Guzmán-Holst A
    Hum Vaccin Immunother; 2022 Nov; 18(6):2102353. PubMed ID: 36084255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Routine Vaccination Coverage, 2018.
    Peck M; Gacic-Dobo M; Diallo MS; Nedelec Y; Sodha SV; Wallace AS
    MMWR Morb Mortal Wkly Rep; 2019 Oct; 68(42):937-942. PubMed ID: 31647786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine.
    Faingezicht I; Avila-Aguerro ML; Cervantes Y; Fourneau M; Clemens SA
    Rev Panam Salud Publica; 2002 Oct; 12(4):247-57. PubMed ID: 12431356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles control in Sub-Saharan Africa: South Africa as a case study.
    Verguet S; Jassat W; Hedberg C; Tollman S; Jamison DT; Hofman KJ
    Vaccine; 2012 Feb; 30(9):1594-600. PubMed ID: 22230581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Challenge of Achieving Immunity Through Multiple-Dose Vaccines in Madagascar.
    Jones FK; Mensah K; Heraud JM; Randriatsarafara FM; Metcalf CJE; Wesolowski A
    Am J Epidemiol; 2021 Oct; 190(10):2085-2093. PubMed ID: 34023892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine Vaccination Coverage - Worldwide, 2021.
    Rachlin A; Danovaro-Holliday MC; Murphy P; Sodha SV; Wallace AS
    MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(44):1396-1400. PubMed ID: 36327156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Routine Vaccination Coverage, 2015.
    Casey RM; Dumolard L; Danovaro-Holliday MC; Gacic-Dobo M; Diallo MS; Hampton LM; Wallace AS
    MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(45):1270-1273. PubMed ID: 27855146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.